Results 71 to 80 of about 26,677 (229)

A recurrent giant cell tumor of bone treated with denosumab

open access: yesClinics and Practice, 2015
Although the giant cell tumor of bone is generally classified as a benign tumor it can rarely metastasize and has a potential risk of local recurrence. We want to report about a female patient who suffered from a recurrence of a giant cell tumor of bone ...
Nicola Stadler   +3 more
doaj   +1 more source

Expert Perspective: Hematologic Malignancies and Vasculitis

open access: yes
Arthritis &Rheumatology, EarlyView.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

open access: yesMed Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin   +8 more
wiley   +1 more source

Features of histological structure and differential diagnostics of the diffuse-type giant cell tumor and its malignant form.

open access: yesМорфологія, 2016
Background. Tenosynovial giant cell tumor of diffuse type is one of the most widespread tumor of joints, causing destruction of the soft tissues and bone articular surfaces. Objective.
E. A. Dyadyk, A. V. Hryhorovska
doaj   +1 more source

Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background This study analyzed the clinical features of central nervous system involvement (CNS3) in pediatric anaplastic large cell lymphoma (ALCL) and evaluated the CNCL‐ALCL‐2017 treatment protocol efficacy. Methods The clinical data of 215 pediatric ALCL patients aged ≤18 years, including 16 with CNS3, treated following the CNCL‐ALCL‐2017 ...
Xiaomei Yang   +29 more
wiley   +1 more source

Pseudoanaplastic Giant Cell Tumor of Bone

open access: yesArchives of Pathology & Laboratory Medicine, 1999
AbstractMarked nuclear atypia can be found in a variety of benign mesenchymal tumors, including ancient schwannomas, symplastic leiomyomas, osteoblastomas, and chondromyxoid fibromas. Such nuclear atypia is believed to represent a degenerative phenomenon and does not indicate aggressive behavior.
Joseph M. Mirra   +2 more
openaire   +3 more sources

Vertebral canine myxosarcoma with neurological signs treated by vertebroplasty and radiotherapy (in a dog)

open access: yesVeterinary Record Case Reports, EarlyView.
Abstract Canine myxosarcomas are an uncommon group of tumours, with therapeutic modalities still under research. This case report describes a vertebral myxosarcoma in a 5‐year‐old, mixed‐breed dog causing pelvic limb ataxia. Diagnostic modalities included computed tomography and histopathology.
Flavie Deschildre   +4 more
wiley   +1 more source

Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab

open access: yesCase Reports in Medicine, 2015
Giant cell tumor (GCT) of bone is a generally benign, but often locally aggressive, neoplasm of bone, with a propensity for recurrence. Sarcomatous transformation is rare and typically occurs with a history of recurrences and radiation treatment ...
Cory Julian Broehm   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy